Medical Research News
Focus on the latest clinical studies, reports, findings, programs and standards covering a wide spectrum of medical and health issues. This section highlights research into human populations and includes information about research facilities, funding, resources and public policy.
Hematologist-Oncologist Dr. Anurag Sharma Joins New York Cancer & Blood Specialists in Middletown
New York Cancer & Blood Specialists (NYCBS) is proud to announce the addition of board-certified hematologist-oncologist Anurag Sharma, MD. - October 15, 2024 - New York Cancer & Blood Specialists
Pennington Biomedical Partners on Army-Wide Health and Nutrition Study
Pennington Biomedical’s Center for Military Performance and Resilience and the U.S. Army Research Institute of Environmental Medicine collaborate on study; Louisiana’s Fort Johnson is first installation visit for study. - October 06, 2024 - Pennington Biomedical Research Center
Adapy, Inc. Awarded Phase 1 SBIR Grant by NIDILRR to Advance Mobility Solutions
Adapy, Inc. has received a Phase 1 SBIR grant from NIDILRR to advance its innovative harness technology interfacing with its Smart Mobility System. This grant supports Adapy’s mission to improve mobility for individuals with disabilities, enhancing safety and independence. - October 02, 2024 - Adapy, Inc.
Greenberg Regenerative Medicine Celebrates Nearing 2 Years of Success with Pioneering VSEL Therapy
Greenberg Regenerative Medicine is approaching its two-year milestone of offering Very Small Embryonic-Like (VSEL) stem cell therapy at their Bryn Mawr, PA clinic. VSEL therapy has proven highly effective in treating diverse conditions by enhancing the body’s natural healing. Under Dr. Scott Greenberg's leadership, VSEL therapy is now a key component of their advanced regenerative treatment offerings. - September 27, 2024 - Greenberg Regenerative Medicine
Nurse Lynx Welcomes Colleen Agate as Co-Founder and Chief Marketing Officer
Nurse Lynx, the innovative healthcare staffing platform transforming how healthcare providers connect with qualified professionals, proudly announces Colleen Agate as Co-Founder and Chief Marketing Officer (CMO). Colleen’s extensive experience in marketing, technology, and business strategy... - September 15, 2024 - nurse lynx inc
Sama Therapeutics and Quine Biologics Announce Collaboration to Develop Breakthrough Antibody Therapeutics for Neurological Disorders
Sama Therapeutics and Quine Biologics have partnered to develop an innovative therapy for neurological disorders, combining AI-driven platforms and advanced antibody engineering. The collaboration focuses on biologics that precisely target the central nervous system, minimizing side effects. By integrating Sama's generative AI with Quine's antibody design expertise, the project addresses unmet medical needs and advances treatments for conditions like Alzheimer’s and multiple sclerosis. - September 13, 2024 - Quine Biologics, Inc.
Microvascular Therapeutics Announce Completion of Phase 2 Study Enrollment for MVT-100
Microvascular Therapeutics (MVT), a pioneering healthcare research and development company, is pleased to announce the completion of enrollment in MVT’s Phase 2 program using its microbubble product, MVT-100, for endocardial border delineation. This study, An Ascending Dose Comparison of... - September 13, 2024 - Microvascular Therapeutics, Inc.
Krea Launches HOPE: An AI-Powered Synthetic Healthcare Panel for India
Krea, a Global Precision Health Insights Company, is unveiling HOPE (Hybrid Optimized Profiles and Engagement), an innovative solution designed to transform healthcare market research. In this first release, HOPE focuses on the patient segment. Healthcare research often struggles with limited... - September 10, 2024 - Krea
Hemanext Inc. Announces New HCPCS Code for “Red Blood Cells, Leukocytes Reduced, Oxygen/Carbon Dioxide Reduced, Each Unit”
The Centers for Medicare & Medicaid Services (CMS) has officially issued a new Healthcare Common Procedure Coding System (HCPCS) code for “Red blood cells, leukocytes reduced, oxygen/carbon dioxide reduced, each unit,” an innovative blood transfusion product produced by the Hemanext ONE Red Blood Cell Processing and Storage System. - September 09, 2024 - Hemanext
Huntington Study Group and HD Genetics Collaborate to Better Serve HD Gene Positive Patients
The Huntington Study Group® and HSG Clinical Research, Inc. (together, “HSG”) are pleased to announce a strategic partnership with HD Genetics to assist patients who have tested positive for Huntington’s disease (HD) learn about and enroll in research studies. There remains a... - September 05, 2024 - Huntington Study Group
ALS Therapy Development Institute Commemorates 25th Anniversary at the Leadership Weekend in October
Taking place from October 3-5, 2024, in the Boston area, ALS TDI’s Leadership Weekend features a series of community-focused events, including an Open House at ALS TDI’s cutting-edge research lab, the ALS TDI Research Summit, and the White Coat Affair gala. - September 03, 2024 - ALS Therapy Development Institute
PCOS Awareness Association and Milan Laser Hair Removal Present: Empower & Illuminate - a PCOS Advocacy Event
In a powerful collaboration aimed at raising awareness and advocating for those affected by Polycystic Ovarian Syndrome (PCOS), the PCOS Awareness Association and Milan Laser Hair Removal are proud to announce the "Empower & Illuminate: A PCOS Advocacy Event." This groundbreaking... - August 21, 2024 - PCOS Awareness Association
Huntington Study Group Announces New CEO
The Huntington Study Group® and HSG Clinical Research, Inc. (together, “HSG”) are pleased to announce that Daniel Claassen, MD, MS, an internationally recognized Huntington’s Disease neurologist and researcher has accepted the role as the organization’s Chief Executive... - August 20, 2024 - Huntington Study Group
Hemanext Inc. Announces Completion of Cancer and Burn Safety Study, a Significant Milestone for the Hemanext ONE® Innovative Red Blood Cell Processing and Storage System
The post-market clinical study in Bergen, Norway, that was designed to assess the safety of transfusing hypoxic red blood cells (RBCs) in patients with acute burns and hematological malignancies, has been completed. - August 20, 2024 - Hemanext
Blink DC Launches Its Second Generation TwitchView® System, A Quantitative Neuromuscular Monitor
Blink Device Company announces the launch of the TwitchView®2 System, the second generation of its electromyographic (EMG) quantitative neuromuscular monitoring system. A complete redesign based on experience in over 1,000,000 clinical cases around the world. Designed to withstand OR abuse and to perform reliably in even the most difficult-to-monitor patients. - August 14, 2024 - Blink Device Company
Labdx4u Launches Affordable Lab Testing Services with No Insurance Required
Labdx4u is dedicated to providing affordable, accurate lab testing services to individuals, regardless of their insurance status. With a focus on accessibility, reliability, and customer satisfaction, Labdx4u aims to empower people to take control of their health through comprehensive and cost-effective lab testing solutions. - August 10, 2024 - Labdx4u
Parvus Therapeutics Announces Leadership Appointments to Support Development from Preclinical Into Clinical
New Positions Enhance Parvus Capability to Execute the Translation of Multiple Drug Candidates into the Clinic. - August 06, 2024 - Parvus Therapeutics U.S., Inc.
Pennington Biomedical Scientists Outline Key Challenges and Promising Avenues in Obesity Genetics
Research article by Pennington Biomedical’s Dr. Sujoy Ghosh and Dr. Claude Bouchard included in the International Journal of Obesity - August 02, 2024 - Pennington Biomedical Research Center
New Study Explores Potential Benefits of Biophoton Generators in Alzheimer's Care
Study results shared at Alzheimer's Association International Conference in Philadelphia. - July 30, 2024 - Tesla BioHealing, Inc.
Parvus Therapeutics Has Received Orphan Drug Designation for Primary Biliary Cholangitis and Human Research Ethics Committee Approval to Begin Clinical Testing
Parvus Therapeutics announced today that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to PVT201 for the treatment of Primary Biliary Cholangitis (PBC) and PVT201 has obtained Australian Human Research Ethics Committee (HREC) approval to initiate a first-in-human... - July 29, 2024 - Parvus Therapeutics U.S., Inc.
Clinical Studies Highlight the Potential of Tesla BioHealing Biophoton Generator in Improving Mobility for Chronic Stroke Patients
Clinical studies indicate that the Tesla BioHealing® Biophoton Generator may help enhance mobility in patients with chronic stroke conditions. - July 24, 2024 - Tesla BioHealing, Inc.
New Book from Oaklea Press Unveils Viable Solution to the Opioid Addiction Crisis
A new release from Oaklea Press relates the story of a man who became addicted to opioids prescribed to quell pain from cancer surgery. Realizing he would eventually die as a result, he invented a device that enabled him to taper his addiction until he was completely free of opioids. - July 22, 2024 - The Oaklea Press
MC4R Agonist Drug Candidates Demonstrate Potential to Transform GLP1 Obesity Therapy
Courage Therapeutics announced new evidence of synergy between MC4R agonists and GLP1RA drugs in a paper published in the Journal of Clinical Investigation led by co-founder Dr. Roger Cone. The company has completed a drug discovery campaign to invent a best in class portfolio of MC4R agonists for obesity in order to leverage the synergy. Potential combinations with drugs such as Ozempic and Mounjaro could improve side effects such as nausea and GI discomfort while driving increased weight loss. - July 16, 2024 - Courage Therapeutics
Visualizing Addiction: How New Research Could Change the Way We Fight the Opioid Epidemic
New research from a Max Planck Florida Institute for Neuroscience researcher could transform how we understand the way opioids affect the brain. Current understanding of how opioids function in the brain is quite limited, primarily due to challenges in observing and measuring opioid effects in real-time. A recent breakthrough, led by Dr. Lin Tian and her research team and collaborators and published in Nature Neuroscience, is set to transform how scientists study opioid signaling in the brain. - July 16, 2024 - Max Planck Florida Institute for Neuroscience
SYNAPS Dx Welcomes Renowned Alzheimer’s Researcher, Dr. Donna Wilcock, to Its Scientific Advisory Board
SYNAPS Dx welcomes Dr. Donna M. Wilcock, a leading Alzheimer's researcher, to its Scientific Advisory Board. Dr. Wilcock's expertise in neuroinflammation and vascular cognitive impairment will support the advancement of the DISCERN™ diagnostic test for Alzheimer's disease. This addition reinforces SYNAPS Dx’s commitment to pioneering accurate, minimally invasive diagnostics for Alzheimer's. For more info, visit SYNAPS Dx's website. - July 15, 2024 - SynapsDx
Huntington Study Group Announces Launch of LEAD-HD Observational Study
The Huntington Study Group® and HSG Clinical Research, Inc. (together, “HSG”) today announce the release of their newest Patient Reported Outcomes (PRO) study, LEAD-HD. This observational study was developed collaboratively with the University of Rochester Center for Health +... - July 15, 2024 - Huntington Study Group
Rosario S. Cassata of the Cassata Foundation Proudly Supports the Northwell Health Foundation and Huntington Hospital on Long Island, NY
For over 8 years, Rosario and Carolyn Cassata of The Cassata Foundation have proudly supported the Northwell Health Foundation and Huntington Hospital on Long Island Their generous contributions have helped fulfill their mission of providing comprehensive care and survivorship services for cancer... - July 09, 2024 - The Cassata Foundation
Immundiagnostik, Inc. Partners with BioPorto Diagnostics A/S to Expand Renal Research Offering
Immundiagnostik, Inc. has partnered with BioPorto Diagnostics A/S to expand its product portfolio to include BioPorto's line of NGAL ELISAs. - July 01, 2024 - Immundiagnostik, Inc.
Superhero Support and Montgomery County Comic & Cosplay Club - RisuCon2024 Team Up for Prune Belly Syndrome Research
Superhero Support, a non-profit organization bringing the power of costumed heroes to good causes, and the Montgomery County Comic & Cosplay Club, a fellow non-profit group celebrating comics, anime, and cosplay, are thrilled to announce a unique partnership at RisuCon 2024. This exciting... - June 26, 2024 - Superhero Support Inc.
Cambridge Polymer Group Unveils Restructure to Accelerate Client Innovation through Material Science
Cambridge Polymer Group (CPG) announced a new leadership structure to better support clients in developing innovative products. CPG is creating a new five-person senior management team with deep materials science expertise, which will allow for closer collaboration with clients on complex projects. Dr. Gavin Braithwaite will be the new CEO and Dr. Stephen Spiegelberg will move to the new role of Chief Scientific Officer (CSO). - June 23, 2024 - Cambridge Polymer Group
Pioneering Cancer Treatment: the Successful Partnership Between MAIA Biotechnology and Cromos Pharma
MAIA Biotechnology, a leader in targeted therapy and immuno-oncology, partnered with Cromos Pharma, an international CRO, to advance cancer treatment. At ASCO 2024, MAIA unveiled promising interim data for THIO, a telomere-targeting agent for NSCLC, showing an 85% disease control rate with THIO and Libtayo in advanced patients. Cromos excelled in patient recruitment and regulatory approvals in key European countries. This collaboration underscores their commitment to revolutionizing cancer care. - June 22, 2024 - Cromos Pharma
Cayman Chemical Expands Molecular Diagnostic Research Offerings Through Partnership with PCRassays.com
Cayman Chemical, a leading supplier of research tools for the life science community, has widened their portfolio to include molecular-based detection kits through a strategic partnership with PCRassays.com. PCRassays.com offers more than 200 qPCR-based assays for infectious diseases, over 50 of... - June 07, 2024 - Cayman Chemical Company
Immundiagnostik, Inc. Launches New and Improved Website
Immundiagnostik, Inc. announces the launch of its new and improved website, making it easier for researchers and clinical lab professionals to find the immunoassays and ELISAs they need. - June 03, 2024 - Immundiagnostik, Inc.
International Perinatal Stem Cell Society, Inc. and TRI-PAC Health and Wellness Advocacy Have Formed a Strategic Alliance to Advance Stem Cell Legislation
The International Perinatal Stem Cell Society, Inc. and TRI-PAC Health and Wellness Advocacy have formed a strategic alliance to advocate for legal access to safe, effective, and affordable stem cell therapies in the United States. They propose adopting the Japanese model for stem cell therapy regulation, allowing patients to participate in paid clinical trials. The partnership aims to draft and propose a federal bill to improve patient access to stem cell and tissue therapies. - May 24, 2024 - International Perinatal Stem Cell Society, Inc.
Suabix™ Now Live; Revolutionizing Healthcare with Cutting-Edge AI Human Factors Copilot and Consulting Services for Product Development Teams
Suabix™ by Successful Human Factors™, is the first AI Human Factors Copilot for medical product teams, revolutionizing the future of healthcare and patient safety. Successful Human Factors™ is also offering AI integration services tailored to stakeholders needs, powered by Suabix. - May 21, 2024 - Successful Human Factors™
The Healthcare Education, Research and Innovation Foundation and MATTER Launch Innovation Challenge to Advance Health Equity Solutions
The Healthcare Education, Research and Innovation Foundation and MATTER launch innovation challenge to advance health equity solutions developed by college students and early career professionals. Up to five finalists will be selected to participate in eight-week accelerator with the chance to win... - May 03, 2024 - HERIF-Healthcare Education, Research and Innovation Foundation
Revolutionizing Clinical Trials: AnzuBridge Unveils Next-Generation Solutions for Improved Efficacy Evaluations in the Treatment of Rare Disease
AnzuBridge® updates its CDMS to enhance biotech evaluations with advanced video tools, ensuring precise efficacy recording and compliance. It supports scalable trials and features HIPAA-compliant media capture, ePRO for patient engagement, and sophisticated video review capabilities, all integrated with a Learning Management System for efficient trial management. - April 30, 2024 - Anzu
Huntington Study Group Launches Project AWARE 2.0 Observational Study
The Huntington Study Group® and HSG Clinical Research, Inc. (together, “HSG”) are pleased to announce the launch of Project AWARE 2.0, an observational study developed in collaboration with Roche Products Limited and Genentech to understand and improve Awareness, Willingness, and... - April 10, 2024 - Huntington Study Group
Ngram Expands AI Dataset Offerings with Descriptive Question Answering for Healthcare
New open-source medchat-qa-descriptive dataset enables AI models to provide comprehensive answers to complex medical queries. - March 22, 2024 - ngram Inc.
AMD Stopper, a New Treatment for Age-Related Macular Degeneration, Seeks Partnerships with Manufacturers in the Healthcare Industry
California inventor of oral treatment for Age-Related Macular Degeneration, a common eye disease which affects tens of millions globally, is working tirelessly to bring his formulation to market. - March 20, 2024 - AMD Stopper
The University of Iowa Selects TrialX to Build SAYSTOP Study App for a Leading Research Study to Investigate Antibiotics Resistance
To study a patient-centered approach to antibiotic discontinuation upon symptom resolution in patients with acute uncomplicated pyelonephritis. - March 13, 2024 - TrialX
Innovation in Healthcare: Medical Websites Vie for Coveted Best Medical Website WebAward
The Web Marketing Association is looking for the best medical websites in the world as part of their 28th annual international WebAward Competition for Web site development at www.webaward.org. The WebAwards is the standards-defining competition that sets benchmarks for 90 industries, including healthcare, healthcare provider, medical, medical equipment, biotechnology and pharmaceutical websites. - March 13, 2024 - Web Marketing Association
iView Therapeutics Inc. Announced FDA’s Clearance of IND Application for IVW-1001 Ophthalmic Eyelid Wipe to Treat Signs and Symptoms of Dry Eye Disease
iView Therapeutics Inc., a clinical stage biotechnology company dedicated to advancing innovative treatments for ocular diseases, announces that the U.S. Food and Drug Administration (FDA) cleared iView’s Investigational New Drug (IND) application to for the initiation of a Phase 1/2 clinical... - March 11, 2024 - iView Therapeutics Inc.
ALS TDI Launches ALS Trial Navigator: A Revolutionary Platform to Simplify Access to Clinical Trials
The ALS Therapy Development Insitute (ALS TDI) has announced the beta launch of the ALS Trial Navigator. This innovative set of tools is designed to guide people with ALS and caregivers through the process of finding and understanding ALS clinical trials – with the ultimate goal of personalizing the search process and helping users make informed decisions about participation in trials. - February 29, 2024 - ALS Therapy Development Institute
IVIEW Announces Presentation of Positive Topline Results in Phase II Clinical Study of IVIEW-1201 for the Treatment of Bacterial Conjunctivitis at ARVO 2024
IVIEW Therapeutics Inc. announces to present the positive topline result in the Phase II Clinical Study of IVIEW-1201 for the Treatment of Bacterial Conjunctivitis in the upcoming 2024 ARVO (The Association for Research in Vision and Ophthalmology) national meeting in Seattle, WA. The Presentation... - February 28, 2024 - iView Therapeutics Inc.
New Research Findings Show That Life Span Can be Increased by Making Cells Less Efficient at Producing Energy
Pennington Biomedical Researchers Looking for New Ways to Improve Life Span and Health During Aging - February 23, 2024 - Pennington Biomedical Research Center
Cayman Chemical Introduces LipidLaunch™, Expands Portfolio of Lipid Nanoparticle Research Tools to Support Advances in RNA Therapies
Cayman Chemical introduces the latest addition to the company’s portfolio of lipid nanoparticle (LNP) research tools for academic, pharma, and biotech researchers worldwide. The LipidLaunch™ product line helps researchers pursue LNPs for the delivery of nucleic acid therapies in untold health applications, ranging from vaccine development to cancer and cell or gene therapies. - February 22, 2024 - Cayman Chemical Company
Researchers Combine Modern Equipment for Increased Precision in Body Composition Analysis
Pennington Biomedical Professor of Metabolism and Body Composition Dr. Steven Heymsfield is part of a team of researchers who confirm the results in the study: "Generative Deep Learning Furthers the Understanding of Local Distributions of Fat and Muscle on Body Shape and Health Using 3D Surface Scans." - February 21, 2024 - Pennington Biomedical Research Center
Pennington Biomedical's Dr. Jeffery Keller to Lead Answer ALS' Open Access Data Repository
Pennington Biomedical's Dr. Jeffery Keller has been named Principal Investigator to oversee Answer ALS' open access data repository, Neuromine. Serving as Director for Pennington Biomedical's Institute for Dementia Research and Prevention and a Professor of Aging and Neurodegeneration, Dr. Keller... - February 14, 2024 - Pennington Biomedical Research Center
Biopharmaceutical Sponsor Interaction with Clinical Site Networks Pulse Report
Sponsor Outsourcing Dollars May Shift to Clinical Site Networks, Transforming the CRO Relationship - February 13, 2024 - Life Science Strategy Group, LLC